SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Katarzyna Kaminska, Cezary Szczylik, Fei Lian, Anna M Czarnecka, The role of prostaglandin E2 in renal cell cancer development: future implications for prognosis and therapy, Future Oncology, 2014, 10, 14, 2177

    CrossRef

  2. 2
    Zu-Hu Yu, Qiang Zhang, Ya-Dong Wang, Jing Chen, Zhi-Mao Jiang, Min Shi, Xin Guo, Jie Qin, Guang-Hui Cui, Zhi-Ming Cai, Yao-Ting Gui, Yong-Qing Lai, Overexpression of Cyclooxygenase-1 Correlates with Poor Prognosis in Renal Cell Carcinoma, Asian Pacific Journal of Cancer Prevention, 2013, 14, 6, 3729

    CrossRef

  3. 3
    Sarfraz Ali, Qiqin Yin-Goen, Timothy V. Johnson, Wei Han, Nicole A. Johnson, Wayne B. Harris, Fray F. Marshall, Andrew N. Young, Viraj A. Master, Adeboye O. Osunkoya, Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients, Tumor Biology, 2011, 32, 2, 375

    CrossRef

  4. 4
    Hanna Ronkainen, Markku H. Vaarala, Pasi Hirvikoski, Ari Ristimäki, HuR expression is a marker of poor prognosis in renal cell carcinoma, Tumor Biology, 2011, 32, 3, 481

    CrossRef

  5. 5
    Rebecca A. Rozich, David R. Mills, Kate E. Brilliant, Helen M. Callanan, DongQin Yang, Umadevi Tantravahi, Douglas C. Hixson, Accumulation of neoplastic traits prior to spontaneous in vitro transformation of rat cholangiocytes determines susceptibility to activated ErbB-2/Neu, Experimental and Molecular Pathology, 2010, 89, 3, 248

    CrossRef

  6. 6
    Jin F. Li, Yi W. Chu, Guo M. Wang, Tong Y. Zhu, Rui M. Rong, Jun Hou, Ming Xu, The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma, BJU International, 2009, 103, 3
  7. 7
    Sinan Sozen, Serhat Gurocak, Ozlem Erdem, Cenk Acar, Yakup Kordan, Gulen Akyol, Turgut Alkibay, Cyclooxygenase-2 expression: Does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma?, International Urology and Nephrology, 2008, 40, 2, 295

    CrossRef

  8. 8
    Jaiyeola O. Thomas, Ossama W. Tawfik, Recent advances in the diagnosis of renal cell carcinoma, Diagnostic Histopathology, 2008, 14, 4, 157

    CrossRef

  9. 9
    John A Taylor III, Carol Pilbeam, Andrew Nisbet, Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies, Expert Review of Anticancer Therapy, 2008, 8, 7, 1125

    CrossRef

  10. 10
    Gavin W.A. Lamb, Peter A. McArdle, Sara Ramsey, Anne-Marie McNichol, Joanne Edwards, Michael Aitchison, Donald C. McMillan, The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer, BJU International, 2008, 102, 6
  11. 11
    Ayhan Dirim, Asuman Nihan Haberal, Mehmet Resit Goren, Mehmet Ilteris Tekin, Levent Peskircioglu, Beyhan Demirhan, Hakan Ozkardes, VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value, International Urology and Nephrology, 2008, 40, 4, 861

    CrossRef

  12. 12
    Monika K. Krzyzanowska, Ian F. Tannock, Gina Lockwood, Jennifer Knox, Malcolm Moore, Georg A. Bjarnason, A phase II trial of continuous low-dose oral cyclophosphamide and celecoxib in patients with renal cell carcinoma, Cancer Chemotherapy and Pharmacology, 2007, 60, 1, 135

    CrossRef

  13. 13
    Evelyn Neppelberg, Anne Christine Johannessen, DNA content, Cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus, European Archives of Oto-Rhino-Laryngology, 2007, 264, 10, 1223

    CrossRef

  14. 14
    Konstantinos Giannitsas, Agelis Konstantinopoulos, Petros Perimenis, Non-steroidal anti-inflammatory drugs in the treatment of genitourinary malignancies: focus on clinical data, Expert Opinion on Investigational Drugs, 2007, 16, 11, 1841

    CrossRef

  15. 15
    Y Hori, Y Oda, K Kiyoshima, Y Yamada, Y Nakashima, S Naito, M Tsuneyoshi, Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis, The Journal of Pathology, 2007, 212, 2
  16. 16
    M. Ugur Mungan, Duygu Gurel, A. Erdem Canda, Burcin Tuna, Kutsal Yorukoglu, Ziya Kirkali, Expression of COX-2 in Normal and Pyelonephritic Kidney, Renal Intraepithelial Neoplasia, and Renal Cell Carcinoma, European Urology, 2006, 50, 1, 92

    CrossRef

  17. 17
    Brian I. Rini, Vivian Weinberg, Sarah Dunlap, Alexandra Elchinoff, Nancy Yu, Robert Bok, Jeffery Simko, Eric J. Small, Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma, Cancer, 2006, 106, 3
  18. 18
    Miguel García-González, Ihab Abdulkader, Angel Vázquez Boquete, Xosé Manuel Lens Neo, Jerónimo Forteza, José Cameselle-Teijeiro, Cyclooxygenase-2 in normal, hyperplastic and neoplastic follicular cells of the human thyroid gland, Virchows Archiv, 2005, 447, 1, 12

    CrossRef

  19. 19
    Madoka Sakurai, Kenji Oishi, Kikuko Watanabe, Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma, Biochemical and Biophysical Research Communications, 2005, 338, 1, 82

    CrossRef